van der Graaf Marinette, Julià-Sapé Margarida, Howe Franklyn A, Ziegler Anne, Majós Carles, Moreno-Torres Angel, Rijpkema Mark, Acosta Dionisio, Opstad Kirstie S, van der Meulen Yvonne M, Arús Carles, Heerschap Arend
Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
NMR Biomed. 2008 Feb;21(2):148-58. doi: 10.1002/nbm.1172.
This paper reports on quality assessment of MRS in the European Union-funded multicentre project INTERPRET (International Network for Pattern Recognition of Tumours Using Magnetic Resonance; http://azizu.uab.es/INTERPRET), which has developed brain tumour classification software using in vivo proton MR spectra. The quality assessment consisted of both MR system quality assurance (SQA) and quality control (QC) of spectral data acquired from patients and healthy volunteers. The system performance of the MR spectrometers at all participating centres was checked bimonthly by a short measurement protocol using a specially designed INTERPRET phantom. In addition, a more extended SQA protocol was performed yearly and after each hardware or software upgrade. To compare the system performance for in vivo measurements, each centre acquired MR spectra from the brain of five healthy volunteers. All MR systems fulfilled generally accepted minimal system performance for brain MRS during the entire data acquisition period. The QC procedure of the MR spectra in the database comprised automatic determination of the signal-to-noise ratio (SNR) in a water-suppressed spectrum and of the line width of the water resonance (water band width, WBW) in the corresponding non-suppressed spectrum. Values of SNR > 10 and WBW < 8 Hz at 1.5 T were determined empirically as conservative threshold levels required for spectra to be of acceptable quality. These thresholds only hold for SNR and WBW values using the definitions and data processing described in this article. A final QC check consisted of visual inspection of each clinically validated water-suppressed metabolite spectrum by two, or, in the case of disagreement, three, experienced MR spectroscopists, to detect artefacts such as large baseline distortions, exceptionally broadened metabolite peaks, insufficient removal of the water line, large phase errors, and signals originating from outside the voxel. In the end, 10% of 889 spectra with completed spectroscopic judgement were discarded.
本文报告了欧盟资助的多中心项目INTERPRET(利用磁共振进行肿瘤模式识别国际网络;http://azizu.uab.es/INTERPRET)中磁共振波谱(MRS)的质量评估情况,该项目利用体内质子磁共振波谱开发了脑肿瘤分类软件。质量评估包括磁共振系统质量保证(SQA)以及对从患者和健康志愿者获取的光谱数据的质量控制(QC)。所有参与中心的磁共振波谱仪的系统性能每两个月通过使用专门设计的INTERPRET体模的简短测量方案进行检查。此外,每年以及每次硬件或软件升级后都会执行更全面的SQA方案。为了比较体内测量的系统性能,每个中心从五名健康志愿者的大脑中获取了磁共振波谱。在整个数据采集期间,所有磁共振系统均满足脑MRS普遍认可的最低系统性能要求。数据库中磁共振波谱的QC程序包括自动测定水抑制谱中的信噪比(SNR)以及相应非抑制谱中的水共振线宽(水带宽,WBW)。经验证,在1.5T时SNR>10且WBW<8Hz的值被确定为光谱质量可接受所需的保守阈值水平。这些阈值仅适用于使用本文所述定义和数据处理的SNR和WBW值。最终的QC检查包括由两名经验丰富的磁共振波谱学家(如有分歧则由三名)对每个经过临床验证的水抑制代谢物谱进行目视检查,以检测诸如大的基线失真、异常加宽的代谢物峰、水线去除不充分、大的相位误差以及来自体素外的信号等伪影。最后,在889份完成光谱判断的波谱中,有10%被舍弃。